These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 19374823

  • 1. [Advance in diagnosis and treatment of intravenous immunogolobulin-resistant Kawasaki disease].
    Zhang Q.
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Apr; 11(4):318-21. PubMed ID: 19374823
    [No Abstract] [Full Text] [Related]

  • 2. Infliximab administration effective in the treatment of refractory Kawasaki disease.
    Accomando S, Liotta A, Maggio MC, Cardella F, Corsello G.
    Pediatr Allergy Immunol; 2010 Nov; 21(7):1091-2. PubMed ID: 20977502
    [No Abstract] [Full Text] [Related]

  • 3. Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective study.
    Son MB, Gauvreau K, Burns JC, Corinaldesi E, Tremoulet AH, Watson VE, Baker A, Fulton DR, Sundel RP, Newburger JW.
    J Pediatr; 2011 Apr; 158(4):644-649.e1. PubMed ID: 21129756
    [Abstract] [Full Text] [Related]

  • 4. Resistant Kawasaki disease.
    Nachiappan J, May M, Hawker RE, Hong P.
    J Paediatr Child Health; 2004 Apr; 40(9-10):576-8. PubMed ID: 15367156
    [No Abstract] [Full Text] [Related]

  • 5. Is there a role for corticosteroids in Kawasaki disease?
    Shulman ST.
    J Pediatr; 2003 Jun; 142(6):601-3. PubMed ID: 12838185
    [No Abstract] [Full Text] [Related]

  • 6. Infliximab as a novel therapy for refractory Kawasaki disease.
    Weiss JE, Eberhard BA, Chowdhury D, Gottlieb BS.
    J Rheumatol; 2004 Apr; 31(4):808-10. PubMed ID: 15088313
    [Abstract] [Full Text] [Related]

  • 7. An update on Kawasaki disease II: clinical features, diagnosis, treatment and outcomes.
    Yim D, Curtis N, Cheung M, Burgner D.
    J Paediatr Child Health; 2013 Aug; 49(8):614-23. PubMed ID: 23647873
    [Abstract] [Full Text] [Related]

  • 8. [Anti TNF-α (infliximab) treatment for intravenous immunoglobulin (IVIG) resistance patients with acute Kawasaki disease the effects of anticytokine therapy].
    Saji T, Takatsuki S, Kobayashi T.
    Nihon Rinsho; 2014 Sep; 72(9):1641-9. PubMed ID: 25518416
    [Abstract] [Full Text] [Related]

  • 9. Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin.
    Dale RC, Saleem MA, Daw S, Dillon MJ.
    J Pediatr; 2000 Nov; 137(5):723-6. PubMed ID: 11060542
    [Abstract] [Full Text] [Related]

  • 10. Resistant Kawasaki disease treated with anti-CD20.
    Sauvaget E, Bonello B, David M, Chabrol B, Dubus JC, Bosdure E.
    J Pediatr; 2012 May; 160(5):875-6. PubMed ID: 22341587
    [Abstract] [Full Text] [Related]

  • 11. [Reply to questions regarding diagnosis and treatment of Kawasaki disease].
    Wang HW.
    Zhonghua Er Ke Za Zhi; 2006 May; 44(5):337-8. PubMed ID: 16780708
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of Kawasaki disease.
    Taddio A, Rosé CD.
    N Engl J Med; 2007 Jun 28; 356(26):2747; author reply 2748. PubMed ID: 17600908
    [No Abstract] [Full Text] [Related]

  • 13. Kawasaki disease in a US army soldier highlights surveillance.
    Chang C, Wood JC, Strickling WA, Walsh DS.
    Int J Dermatol; 2006 Jan 28; 45(1):83-4. PubMed ID: 16426385
    [No Abstract] [Full Text] [Related]

  • 14. [Risk stratification and prediction of resistance to intravenous immunoglobulin in Kawasaki disease].
    Kobayashi T, Inoue Y, Morikawa A.
    Nihon Rinsho; 2008 Feb 28; 66(2):332-7. PubMed ID: 18260333
    [Abstract] [Full Text] [Related]

  • 15. [Intravenous immunoglobulin-resistant Kawasaki disease with hemophagocytosis].
    Servel AC, Vincenti M, Darras JP, Lalande M, Rodière M, Filleron A.
    Arch Pediatr; 2012 Jul 28; 19(7):741-4. PubMed ID: 22652521
    [Abstract] [Full Text] [Related]

  • 16. Severe cutaneous manifestations in a child with refractory Kawasaki disease.
    Falcini F, Ricci L, Poggi GM, Simonini G, Calabri GB, de Martino M.
    Rheumatology (Oxford); 2006 Nov 28; 45(11):1444-5. PubMed ID: 16847007
    [No Abstract] [Full Text] [Related]

  • 17. Recent developments and controversies in Kawasaki disease.
    Guzman-Cottrill JA, Shulman ST.
    Minerva Pediatr; 2004 Feb 28; 56(1):51-61. PubMed ID: 15249914
    [Abstract] [Full Text] [Related]

  • 18. Kawasaki disease in a two-month-old infant.
    Nso Roca AP, Aracil Santos FJ, del Castillo Martín F, García Guereta L.
    Turk J Pediatr; 2010 Feb 28; 52(2):227-8. PubMed ID: 20560266
    [No Abstract] [Full Text] [Related]

  • 19. Should infliximab be used as an adjuvant to IVIG in the treatment of children with Kawasaki disease who are at high risk for resistance to conventional therapy?
    Davies S, Gold-von Simson G.
    Pediatr Cardiol; 2013 Oct 28; 34(7):1756. PubMed ID: 23771701
    [No Abstract] [Full Text] [Related]

  • 20. Cardiology patient pages. Kawasaki disease.
    Baker AL, Newburger JW.
    Circulation; 2008 Aug 12; 118(7):e110-2. PubMed ID: 18695195
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.